Explore our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts.
Referenced By
Our trackers offer data on key areas of the psychedelic field, including drug development pipelines and policy reform activity.
Our job board features roles across the psychedelics field. Join our talent pool to stay abreast of opportunities.
Our Psychedelic Drug Development Tracker offers an overview of the psychedelic medicine pipeline.
A Pα+ tool that allows you to monitor the status of psychedelics-related bills working their way through both state and federal legislatures in the U.S.
Explore the psychedelic pipeline via our one-stop drug development tracker: from discovery through to approval.
Stay abreast of current progress in psychedelic drug policy reform with our legalization and decriminalization tracker.
Charts and visualisations of our in-house data to provide an overview of the volume and characteristics of investment in the psychedelics sector.
Explore our curated series of headline figures, charts and data visualisations to learn how various groups perceive and interact with psychedelics.
A directory of psychedelic companies, with a focus on drug development, along with summaries of each organisation’s activity.
Charts that visualise the extent of psychedelics organisations’ lobbying activities at the federal level, at least according to filings. Updated quarterly.
Our psychedelic laws tracker is a one-stop resource for psychedelic laws around the world.
A glossary of terms you may come across in the psychedelic space, including relevant regulatory and clinical trial terminology.
Find the latest instalment of our Oregon Tracker, which produces analysis and data visualisations of each cut of data as it is released.
The Psychedelic Library includes digestible explainers on key topics in the development and roll-out of psychedelic-based medicines.
Free subscribers receive a weekly round-up
of news on psychedelics, as well as the occasional article.
Receive regular bulletins, articles, interviews with insiders and quick-take analysis of major stories and developments.
Teams, groups and corporate pricing plans are available, please get in touch via email
to learn more.
Front-row access to the psychedelics space: breaking bulletins, in-depth articles, insider interviews and sharp analysis of the moments that matter—from major trial results and funding rounds to policy shifts shaping the future. Plus, full access to our complete
archive and Library.
Learn More| Free | ||
|---|---|---|
| Weekly Psychedelic News Feed | ||
| Occasional Articles & Free Resources | ||
| Psychedelic Bulletins (In-Depth Briefings, Multiple per Month) | ||
| Quick-Take Analysis of Major Developments | ||
| In-Depth Articles & Deep Dives | ||
| Exclusive Interviews with Insiders & KOLs | ||
| Quarterly Video Briefings | ||
| Exclusive Tools & Data Resources | ||
| Library of Primers & Explainers | ||
|
Subscribe Now |
||
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
By signing up, you agree to our privacy policy. You can unsubscribe at any time.
Aside from group pricing, we also offer bespoke reports and regular briefings. Get in touch to discuss.